Detection of Mycobacterium ulcerans by the loop mediated isothermal amplification method

PLoS Neglected Tropical Diseases

Volumn 6, Issue 4, 2012, Pages

  Ablordey, Anthony ^a   Amissah, Diana Ackon ^a   Aboagye, Isaac Frimpong ^b   Hatano, Ben ^c   Yamazaki, Toshio ^c   Sata, Tetsutaro ^c   Ishikawa, Koichi ^c   Katano, Harutaka ^c  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM DETECTION; BURULI ULCER; CONTROLLED STUDY; DNA EXTRACTION; HUMAN; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MYCOBACTERIUM ULCERANS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; AFRICA SOUTH OF THE SAHARA; COMPARATIVE STUDY; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR DIAGNOSIS; NUCLEIC ACID AMPLIFICATION;

AFRICA SOUTH OF THE SAHARA; BACTERIOLOGICAL TECHNIQUES; BURULI ULCER; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM ULCERANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 84861211298     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001590     Document Type: Article

References (35)

1. World Health Organization (2000) Buruli ulcer. Mycobacterium ulcerans infection. Asiedu K, Scherpbier R, Raviglione M, eds. WHO/CDS/CPE/GBUI/1 WHO, Geneva.
2. Williamson HR, Benbow ME, Nguyen KD, Beachboard DC, Kimbirauskas RK, et al. (2008) Distribution of Mycobacterium ulcerans in Buruli ulcer endemic and non-endemic aquatic sites in Ghana. PLoS Negl Trop Dis 2: e205.
3. World Health Organization (2008) Buruli ulcer disease. Mycobacterium ulcerans infection: an overview of reported cases globally. Wkly Epidemiol Rec 83: 145-156.
4. Sizaire V, Nackers F, Comte E, Portaels F, (2006) Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis 6: 288-96.
5. Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, et al. (2002) Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 8: 167-70.
6. Buntine J, Crofts K, eds. (2001) Buruli ulcer: management of Mycobacterium ulcerans disease: a manual for health care providers Geneva World Health Organization.
7. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, et al. (1999) Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283: 854-857.
8. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, et al. (2004) Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 9 (12): 1297-1304.
9. Meyers WM, Tignokpa N, Priuli GB, Portaels F, (1996) Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo. The British Journal of Dermatology 134: 1116-1121.
10. Asiedu K, Etuaful S, (1998) Socio-economic implications of Buruli ulcer in Ghana: a three-year review. The American Journal of Tropical Medicine and Hygiene 59: 1015-1022.
11. World Health Organization (2000) Buruli ulcer. Mycobacerium ulcerans Infection. WHO/CDS/CPE/GBUI, Geneva.
12. King CH, Ashford DA, Dobos K, Spotts WEA, Raghunathan PL, et al. (2001) Mycobacterium ulcerans Infection and Buruli ulcer Disease: Emergence of a Public Health Dilemma. In: Scheld WM, Craig WA, Hughes JM, editors. Emerging infections. Washington: ASM Press 9: 137-52.
13. World Health Organization (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). World Health Organization, Geneva, Switzerland.
14. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, et al. (2005) Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 49: 3182-3186.
15. Chauty A, Ardant MF, Adeye A, Euverte H, Guedenon A, et al. (2007) Promising clinical efficacy of streptomycin-rifampin combination for treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 51: 4029-4035.
16. Asiedu K, Wansbrough-Jones M, (2007) Mycobacterium ulcerans infection (Buruli or Bairnsdale ulcer): challenges in developing management strategies. Med J Aust 186: 55-6.
17. Bretzel G, Huber KL, Kobara B, Beissner M, Piten E, et al. (2011) Laboratory Confirmation of Buruli ulcer Disease in Togo, 2007-2010. PLoS Negl Trop Dis 5 (7): e1228 doi:10.1371/journal.pntd.0001228.
18. Johnson PD, Hayman JA, Quek TY, Fyfe JA, Jenkin GA, et al. (2007) Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 186: 64-68.
19. Portaels F, Johnson P, Meyers WM, eds. (2001) Buruli ulcer. Diagnosis of Mycobacterium ulcerans disease: a manual for health providers. World Health Organization (WHO) document no. 2001.4 Geneva WHO.
20. Ross BC, Marino L, Oppendisano F, Edwards R, Robins-Browne RM, et al. (1997) Development of a PCR Assay for rapid Diagnosis of Mycobacterium ulcerans Infection. J Microbiol Clin 35 (7): 1696-700.
21. Stinear T, Ross BC, Davies JK, Marino L, Robins-Browne RM, et al. (1999) Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J Clin Microbiol 37: 1018-1023.
22. World Health Organization (2008) Buruli ulcer: progress report, 2004-2008. Wkly Epidemiol Rec 17: 145-154.
23. Walsh DS, Portaels F, Meyers WM, (2011) Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection. Dermatol Clin 29 (1): 1-8.
24. Herbinger KH, Adjei O, Awua-Boateng NY, Nienhuis WA, Kunaa L, et al. (2009) Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis 48: 1055-1064.
25. Beissner M, Herbinger KH, Bretzel G, (2010) Laboratory diagnosis of Buruli ulcer disease. Future Microbiol 5: 363-370.
26. Siegmund V, Adjei O, Racz P, Berberich C, Klutse E, et al. (2005) Dry-reagent-based PCR as a novel tool for laboratory confirmation of clinically diagnosed Mycobacterium ulcerans-associated disease in areas in the tropics where M. ulcerans is endemic. J clin Microbiol 43: 271-276.
27. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, et al. (2000) Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 28: e63.
28. Wang L, Lin L, Alam MJ, Geng Y, Zhiyong L, et al. (2008) Loop-mediated isothermal amplificationmethod for rapid detection of the toxic dinoflagellate Alexandrium, which causes algal blooms and poisoning of shellfish. FEMS Microbiol Lett 282: 15-21.
29. Nagamine K, Hase T, Notomi T, (2002) Accelerated reaction by loop-mediated isothermal amplification using loop primers. Mol Cell Probes 16: 223-229.
30. Poon LLM, Leung CSW, Tashiro M, Chan KH, Wong BWY, et al. (2004) Rapid detection of the severe acute respiratory syndrome (SARS) coronavirus by a loop-mediated isothermal amplification assay. Clin Chem 50: 1050-1052.
31. Iwamoto T, Sonobe T, Hayashi K, (2003) Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium and M. intracellulare in sputum samples. J Clin Microbiol 41: 2616-2622.
32. Kaneko H, Kawana T, Fukushima E, (2007) Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances. J Biochem Biophys Methods 70: 499-501.
33. Jayawardena S, Cheung CY, Barr I, Chan K H, Chen H, et al. (2007) Poon Loop-Mediated Isothermal Amplification for Influenza A (H5N1) Virus. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 6.
34. Hatano B, Maki T, Obara T, Fukumoto H, Hagisawa K, et al. (2010) LAMP using a disposable pocket warmer for anthrax detection, a highly mobile and reliable method for anti-bioterrorism. Jpn J Infect Dis 63: 36-40.
35. Durnez L, Stragier P, Roebben K, Ablordey A, Leirs H, et al. (2009) A comparison of DNA extraction procedures for the detection of Mycobacterium ulcerans, the causative agent of Buruli ulcer, in clinical and environmental specimens. J Microbiol Methods 76: 152-158.